华润材料 reported revenue of ¥7.11B for the period ended 2026-06-30, +3.1% year on year. Net income was ¥0.25B, a 3.6% net margin on a 5.4% gross margin. The largest revenue line is 聚酯产品 at 100% of the total. Free cash flow for the period was ¥-0.28B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥7.11B | +3.1% |
| Gross profit | ¥0.38B | — |
| Operating income | ¥0.22B | — |
| Net income | ¥0.25B | — |
| Gross margin | 5.4% | Net margin 3.6% |
| Revenue Q/Q | +33.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 聚酯产品 | ¥7.09B | 99.8% |
| 原料及其他 | ¥0.02B | 0.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥6.72B | 94.6% |
| R&D | ¥0.01B | 0.2% |
| SG&A | ¥0.09B | 1.3% |
| Tax & other | ¥-0.04B | -0.5% |
| Item | Amount |
|---|---|
| Total assets | ¥9.71B |
| Total liabilities | ¥3.28B |
| Shareholders' equity | ¥6.43B |
| Equity / assets | 66.2% |
| Operating cash flow | ¥-0.28B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.28B |
| Cash conversion (OCF / net income) | -124% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
深城交 ・ 争光股份 ・ 华兰股份 ・ 广立微 ・ 百诚医药 ・ 天益医疗 ・ 金埔园林 ・ 雅创电子 ・ 风光股份 ・ 明月镜片 ・ 兆讯传媒 ・ 何氏眼科
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies